Status:
RECRUITING
Integrative Therapies in Multiple Myeloma
Lead Sponsor:
Bnai Zion Medical Center
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multiple myeloma is a hematologic malignancy that can cause anemia, renal failure, bone disease, and hypercalcemia. Today, myeloma is considered a chronic disease and most patients will receive ongoin...
Eligibility Criteria
Inclusion
- Age over 18
- Diagnosis of multiple myeloma
- Possibility to answer questionnaires once a month in Hebrew, Arabic or Russian
- Signing an informed consent form
Exclusion
- Age under 18 years
- In patients who will receive acupuncture: platelet level below 20x10\^9/L
- In patients who will receive reflexology: deep vein thrombosis in the leg
- Hemodynamic instability
- Psychiatric disorder impairing competence
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06515249
Start Date
July 15 2024
End Date
July 1 2028
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bnai Zion Medical Center
Haifa, Israel, 3339419